Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Get news by email or subscribe to our news feeds.
Health Highlights: July 23, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Ragu Pasta Sauces Recalled Due to Plastic... Read more
FDA Approves Ruxience (rituximab-pvvr), a Biosimilar to Rituxan
July 23, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Ruxience (rituximab-pvvr), a biosimilar to... Read more
Senate Bill Would Reduce Drug Costs for Seniors
TUESDAY, July 23, 2019 -- A bill to reduce prescription drug costs for millions of Medicare recipients and lower federal and state health costs has been... Read more
USPSTF Reaffirms Benefit of Hep B Screening in Pregnant Women
TUESDAY, July 23, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening pregnant women for hepatitis B virus (HBV) infection at their... Read more
Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis
TUESDAY, July 23, 2019 -- Among patients with moderately to severely active rheumatoid arthritis (RA) resistant to previous therapy with biologic agents, a... Read more
2001 to 2017 Saw Increase in Suicides in African-American Teens
TUESDAY, July 23, 2019 -- From 2001 to 2017, the rate of suicides among African-American (AA) adolescents increased, according to a study published in the... Read more
Nonphysican Practitioners Filling Post-ACA Primary Care Gap
TUESDAY, July 23, 2019 -- Primary care practices may be relying on advanced practitioners (APs) to accommodate new Medicaid beneficiaries following the passage... Read more
Mediterranean Diet Has Big Benefits for Expectant Moms: Study
TUESDAY, July 23, 2019 -- Could following a Mediterranean diet during pregnancy help head off gestational diabetes and excess weight gain? A British study says... Read more
Higher Cost of New Cholesterol Drugs Putting Patients at Risk: Study
TUESDAY, July 23, 2019 -- Heart attacks, strokes and other heart problems are more likely in high-risk patients denied access to cutting-edge... Read more
FDA Grants First Approvals for Generic Versions of Lyrica
TUESDAY, July 23, 2019 -- Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug... Read more
AHA News: Early Pregnancy May Be a Prime Time to Promote Heart Health
TUESDAY, July 23, 2019 (American Heart Association News) -- Improving cardiovascular health during the early stages of pregnancy can lead not only to a... Read more
Vertex Submits New Drug Application to the U.S. FDA for Triple Combination Regimen of VX-445 (Elexacaftor), Tezacaftor and Ivacaftor in Cystic Fibrosis
BOSTON--(BUSINESS WIRE)--Jul. 22, 2019-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the submission of a New Drug Application... Read more
Baxter Announces U.S FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion
DEERFIELD, Ill. - July 22, 2019 Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S.... Read more
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 -- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla... Read more
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and... Read more
FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)
Basel, July 16, 2019 - Novartis today announced the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) and... Read more
Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer
TOKYO and BOTHELL, Wash., July 16, 2019 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,... Read more
FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma
JERUSALEM and PARSIPPANY, N.J., July 15, 2019 – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug... Read more
FDA to Review Isatuximab as a Potential Treatment for Relapsed/Refractory Multiple Myeloma
PARIS – July 10, 2019 - The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for isatuximab... Read more
Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease
SAN DIEGO, July 10, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that the U.S. Food and Drug... Read more
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS... Read more
ViiV Healthcare Presents Positive 96-week Data from Phase III Study of Investigational Fostemsavir in Heavily Treatment-Experienced Patients with HIV at IAS 2019
London, UK, 22 July 2019 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as... Read more
Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 22, 2019-- Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people... Read more
Orphazyme to Prepare for Filing of Arimoclomol in US for Niemann-Pick Disease Type C (NPC)
Copenhagen, July 21, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with... Read more
Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
NEW YORK, July 17, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that it has... Read more
